diagnostic-test | Media Room | PressRelease.com

Tagged diagnostic-test

Prolocor Announces Appointment of Raymond Russo as Chief Commercial Officer

Press Release Mar 11, 2024

Prolocor Announces Appointment of Raymond Russo as Chief Commercial Officer

Read More

Prolocor Announces $1.7 Million in Bridge Funding

Press Release Feb 27, 2024

Prolocor Announces $1.7 Million in Bridge Funding

Read More

Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)

Press Release Feb 20, 2024

Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)

Read More

Prolocor Announces Appointment of Edward L. Rosen to Its Board of Directors

Press Release Mar 9, 2023

Prolocor Announces Appointment of Edward L. Rosen to Its Board of Directors

Read More

Prolocor Announces a Combined $5.2 Million in Funding From Seed Round and NIH SBIR Grant

Press Release Aug 16, 2022

Prolocor Announces a Combined $5.2 Million in Funding From Seed Round and NIH SBIR Grant

Read More

Prolocor to Participate at Biotech Showcase 2022

Press Release Jan 10, 2022

Prolocor to Participate at Biotech Showcase 2022

Read More

Press Release Apr 30, 2010

Baltimore Company Launches Improved Test for Breast Cancer Treatment

CCCC Diagnostics, Inc., headquartered in Baltimore, Maryland, has launched the DirectHitTM Test Panel for Breast Cancer, a vastly improved diagnostic test for breast cancer

First
Prev

1

Next
Last